Christiane Walter
Essen, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Prognostic Value of Molecular Genetic Measurable Residual Disease (MRD) Monitoring in Pediatric Acute Myeloid Leukemia Expressing KMT2A::MLLT10.
Journal: European journal of haematology
Published: May 12, 2025
Panel-based RNA fusion sequencing improves diagnostics of pediatric acute myeloid leukemia.
Journal: Leukemia
Published: July 21, 2023
Understanding WT1 Alterations and Expression Profiles in Hematological Malignancies.
Journal: Cancers
Published: May 07, 2023
Impact of KMT2A Rearrangement and CSPG4 Expression in Pediatric Acute Myeloid Leukemia.
Journal: Cancers
Published: September 15, 2021
Survival Following Relapse in Children with Acute Myeloid Leukemia: A Report from AML-BFM and COG.
Journal: Cancers
Published: April 17, 2021
Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study Group.
Journal: Cancers
Published: January 20, 2021
Exposure of Patient-Derived Mesenchymal Stromal Cells to TGFB1 Supports Fibrosis Induction in a Pediatric Acute Megakaryoblastic Leukemia Model.
Journal: Molecular cancer research : MCR
Published: February 05, 2020
Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemia.
Journal: British journal of haematology
Published: October 05, 2019
Evaluation of dsDNA from extracellular vesicles (EVs) in pediatric AML diagnostics.
Journal: Annals of hematology
Published: July 30, 2019
Phospho-Profiling Linking Biology and Clinics in Pediatric Acute Myeloid Leukemia.
Journal: HemaSphere
Published: June 27, 2019
Last Updated: 09/26/2026